Edison Pharmaceuticals, a San Jose, California-based drug developer to treat diseases that impair energy metabolism, has raised $4.25 million in a Series B round. http://edisonpharma.com
Edison Pharmaceuticals, a San Jose, California-based drug developer to treat diseases that impair energy metabolism, has raised $4.25 million in a Series B round. http://edisonpharma.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.